Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Goette

Showing results (101-110 of 194) with videos related to

Pageof 20
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 24, 2020
Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysisAndreas Goette, Lars Eckardt, Marco Valgimigli, et al.
American Heart Journal|May 13, 2015
A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) studyGregory Y H Lip, Jose Merino, Michael Ezekowitz, et al.
Journal of Arrhythmia|June 13, 2020
Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) randomized trialGregory Y H Lip, Jose L Merino, Maciej Banach, et al.
American Heart Journal|February 9, 2018
Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI trialPascal Vranckx, Thorsten Lewalter, Marco Valgimigli, et al.
Journal of Molecular and Cellular Cardiology|December 2, 2017
Progressive impairment of atrial myocyte function during left ventricular hypertrophy and heart failureFlorentina Pluteanu, Yulia Nikonova, Anna Holzapfel, et al.
Circulation|November 27, 2002
Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and strokeHua Cai, Zongming Li, Andreas Goette, et al.
Journal of the American Heart Association|March 4, 2022
AIM-AF: A Physician Survey in the United States and EuropeA John Camm, Carina Blomström-Lundqvist, Giuseppe Boriani, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 24, 2023
Real-world utilization of the pill-in-the-pocket method for terminating episodes of atrial fibrillation: data from the multinational Antiarrhythmic Interventions for Managing Atrial Fibrillation (AIM-AF) surveyJames A Reiffel, Carina Blomström-Lundqvist, Giuseppe Boriani, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 15, 2011
Asymmetric dimethylarginine predicts appropriate implantable cardioverter-defibrillator intervention in patients with left ventricular dysfunctionH Immo Lehmann, Andreas Goette, Jens Martens-Lobenhoffer, et al.
International Journal of Cardiology|February 19, 2013
Effects of irbesartan on gene expression revealed by transcriptome analysis of left atrial tissue in a porcine model of acute rapid pacing in vivoRavi Kumar Chilukoti, Jörg Mostertz, Alicja Bukowska, et al.
Pageof 20

Showing results (101-110 of 194) with videos related to

Sort By:
Pageof 20
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 24, 2020
Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysisAndreas Goette, Lars Eckardt, Marco Valgimigli, et al.
American Heart Journal|May 13, 2015
A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) studyGregory Y H Lip, Jose Merino, Michael Ezekowitz, et al.
Journal of Arrhythmia|June 13, 2020
Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) randomized trialGregory Y H Lip, Jose L Merino, Maciej Banach, et al.
American Heart Journal|February 9, 2018
Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI trialPascal Vranckx, Thorsten Lewalter, Marco Valgimigli, et al.
Journal of Molecular and Cellular Cardiology|December 2, 2017
Progressive impairment of atrial myocyte function during left ventricular hypertrophy and heart failureFlorentina Pluteanu, Yulia Nikonova, Anna Holzapfel, et al.
Circulation|November 27, 2002
Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and strokeHua Cai, Zongming Li, Andreas Goette, et al.
Journal of the American Heart Association|March 4, 2022
AIM-AF: A Physician Survey in the United States and EuropeA John Camm, Carina Blomström-Lundqvist, Giuseppe Boriani, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 24, 2023
Real-world utilization of the pill-in-the-pocket method for terminating episodes of atrial fibrillation: data from the multinational Antiarrhythmic Interventions for Managing Atrial Fibrillation (AIM-AF) surveyJames A Reiffel, Carina Blomström-Lundqvist, Giuseppe Boriani, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 15, 2011
Asymmetric dimethylarginine predicts appropriate implantable cardioverter-defibrillator intervention in patients with left ventricular dysfunctionH Immo Lehmann, Andreas Goette, Jens Martens-Lobenhoffer, et al.
International Journal of Cardiology|February 19, 2013
Effects of irbesartan on gene expression revealed by transcriptome analysis of left atrial tissue in a porcine model of acute rapid pacing in vivoRavi Kumar Chilukoti, Jörg Mostertz, Alicja Bukowska, et al.
Pageof 20